Science News
from research organizations

A new role for an old immune cell may lead to novel therapies for infection and cancer

Date:
March 1, 2017
Source:
University of Birmingham
Summary:
A new study has identified a previously undescribed role for a type of unconventional T cell with the potential to be used in the development of new therapies for infection and cancer.
Share:
FULL STORY

A new study has identified a previously undescribed role for a type of unconventional T cell with the potential to be used in the development of new therapies for infection and cancer.

The study, published today in Nature Communications, shows that Gamma Delta T cells are able to generate immunological memory against previous infections and cancerous targets.

The results challenge the textbook description of Gamma Delta T cells as 'natural born killers' with an innate ability to recognise and destroy abnormal cells.

Lead author of the study, Professor Ben Willcox from the Institute of Immunology and Immunotherapy at the University of Birmingham, explains the key findings: "Instead of being 'natural born killers', we found these cells are actually quite smart. They adapt to and remember what they have encountered in life, which may include infections and pre-cancerous cells.

"This phenomenon of 'immunological memory' is what current vaccines exploit, but because Gamma Delta T cells recognise their targets in a different way, they present novel routes to generate vaccines, and also cell therapy approaches against infection and cancer."

In order to harness these "adaptive" abilities of Gamma Delta T cells, work is now required to identify the mechanism by which they recognise abnormal cells.

"We are working with other partners to understand exactly how these cells recognise signs of abnormality in infection and cancer, focussing on human cohorts. This knowledge will be crucial to help us build on the current study and explore how to develop new cell therapies and vaccines that exploit Gamma Delta T cells," adds Professor Willcox.


Story Source:

Materials provided by University of Birmingham. Note: Content may be edited for style and length.


Journal Reference:

  1. Martin S. Davey, Carrie R. Willcox, Stephen P. Joyce, Kristin Ladell, Sofya A. Kasatskaya, James E. McLaren, Stuart Hunter, Mahboob Salim, Fiyaz Mohammed, David A. Price, Dmitriy M. Chudakov, Benjamin E. Willcox. Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance. Nature Communications, 2017; 8: 14760 DOI: 10.1038/NCOMMS14760

Cite This Page:

University of Birmingham. "A new role for an old immune cell may lead to novel therapies for infection and cancer." ScienceDaily. ScienceDaily, 1 March 2017. <www.sciencedaily.com/releases/2017/03/170301130506.htm>.
University of Birmingham. (2017, March 1). A new role for an old immune cell may lead to novel therapies for infection and cancer. ScienceDaily. Retrieved April 26, 2017 from www.sciencedaily.com/releases/2017/03/170301130506.htm
University of Birmingham. "A new role for an old immune cell may lead to novel therapies for infection and cancer." ScienceDaily. www.sciencedaily.com/releases/2017/03/170301130506.htm (accessed April 26, 2017).